BA Fundamental Analysis - BOEING CO/THE

Fundamental Rating

BA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 71 industry peers in the Aerospace & Defense industry. BA has a bad profitability rating. Also its financial health evaluation is rather negative. BA is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year BA has reported negative net income.

BA had a negative operating cash flow in the past year.

BA had negative earnings in each of the past 5 years.

In multiple years BA reported negative operating cash flow during the last 5 years.

1.2 Ratios

BA has a worse Return On Assets (-6.78%) than 70.42% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROIC	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BA has a worse Gross Margin (1.10%) than 87.32% of its industry peers.

BA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	1.1%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

BA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for BA has been increased compared to 1 year ago.

The number of shares outstanding for BA has been increased compared to 5 years ago.

The debt/assets ratio for BA has been reduced compared to a year ago.

2.2 Solvency

BA has an Altman-Z score of 1.21. This is a bad value and indicates that BA is not financially healthy and even has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of 1.21, BA is doing worse than 81.69% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	1.21

ROIC/WACCN/A

WACC9.3%

2.3 Liquidity

A Current Ratio of 1.18 indicates that BA should not have too much problems paying its short term obligations.

With a Current ratio value of 1.18, BA is not doing good in the industry: 81.69% of the companies in the same industry are doing better.

A Quick Ratio of 0.38 indicates that BA may have some problems paying its short term obligations.

BA has a Quick ratio of 0.38. This is amonst the worse of the industry: BA underperforms 94.37% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.18
Quick Ratio	0.38

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for BA have decreased by -1.07% in the last year.

Looking at the last year, BA shows a quite strong growth in Revenue. The Revenue has grown by 10.18% in the last year.

Measured over the past years, BA shows a decrease in Revenue. The Revenue has been decreasing by -4.74% on average per year.

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

3.2 Future

Based on estimates for the next years, BA will show a very strong growth in Earnings Per Share. The EPS will grow by 20.77% on average per year.

The Revenue is expected to grow by 14.75% on average over the next years. This is quite good.

EPS Next Y51.64%

EPS Next 2Y44.84%

EPS Next 3Y31.77%

EPS Next 5Y20.77%

Revenue Next Year30.18%

Revenue Next 2Y19.7%

Revenue Next 3Y17.43%

Revenue Next 5Y14.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BA. In the last year negative earnings were reported.

BA is valuated quite expensively with a Price/Forward Earnings ratio of 109.51.

Based on the Price/Forward Earnings ratio, BA is valued a bit more expensive than the industry average as 61.97% of the companies are valued more cheaply.

BA is valuated expensively when we compare the Price/Forward Earnings ratio to 24.03, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	109.51

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BA does not grow enough to justify the current Price/Earnings ratio.

A more expensive valuation may be justified as BA's earnings are expected to grow with 31.77% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y44.84%

EPS Next 3Y31.77%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BA does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

BOEING CO/THE

NYSE:BA (12/24/2025, 8:14:32 PM)

After market: 218 -0.16 (-0.07%)

218.16

+1.31 (+0.6%)

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryAerospace & Defense

Earnings (Last)10-29 2025-10-29/bmo

Earnings (Next)01-26 2026-01-26/amc

Inst Owners73.97%

Inst Owner Change1.16%

Ins Owners0.03%

Ins Owner Change-0.19%

Market Cap165.82B

Revenue(TTM)80.76B

Net Income(TTM)-10.17B

Analysts83.43

Price Target256.95 (17.78%)

Short Float %1.95%

Short Ratio1.69

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-19.63%

Min EPS beat(2)-57.93%

Max EPS beat(2)18.67%

EPS beat(4)2

Avg EPS beat(4)-16.78%

Min EPS beat(4)-91.07%

Max EPS beat(4)63.2%

EPS beat(8)5

Avg EPS beat(8)-3.37%

EPS beat(12)6

Avg EPS beat(12)-66.45%

EPS beat(16)6

Avg EPS beat(16)-757.66%

Revenue beat(2)2

Avg Revenue beat(2)1.97%

Min Revenue beat(2)1.11%

Max Revenue beat(2)2.82%

Revenue beat(4)2

Avg Revenue beat(4)-1.87%

Min Revenue beat(4)-8.71%

Max Revenue beat(4)2.82%

Revenue beat(8)3

Avg Revenue beat(8)-1.85%

Revenue beat(12)4

Avg Revenue beat(12)-1.59%

Revenue beat(16)4

Avg Revenue beat(16)-4.27%

PT rev (1m)-2.1%

PT rev (3m)-3.05%

EPS NQ rev (1m)-36.51%

EPS NQ rev (3m)-1069.88%

EPS NY rev (1m)-14.5%

EPS NY rev (3m)-303.23%

Revenue NQ rev (1m)-0.34%

Revenue NQ rev (3m)-1.38%

Revenue NY rev (1m)0.12%

Revenue NY rev (3m)2.05%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	109.51
P/S	2.05
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-15.1

EYN/A

EPS(NY)1.99

Fwd EY0.91%

FCF(TTM)-8.35

FCFYN/A

OCF(TTM)-4.89

OCFYN/A

SpS106.25

BVpS-10.85

TBVpS-22.4

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.78%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	1.1%
FCFM	N/A

ROA(3y)-4.27%

ROA(5y)-4.73%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.54

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	136.76%
Cap/Sales	3.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.18
Quick Ratio	0.38
Altman-Z	1.21

F-Score4

WACC9.3%

ROIC/WACCN/A

Cap/Depr(3y)90.02%

Cap/Depr(5y)74.76%

Cap/Sales(3y)2.43%

Cap/Sales(5y)2.22%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-1.07%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%28.45%

EPS Next Y51.64%

EPS Next 2Y44.84%

EPS Next 3Y31.77%

EPS Next 5Y20.77%

Revenue 1Y (TTM)10.18%

Revenue growth 3Y2.21%

Revenue growth 5Y-4.74%

Sales Q2Q%30.44%

Revenue Next Year30.18%

Revenue Next 2Y19.7%

Revenue Next 3Y17.43%

Revenue Next 5Y14.75%

EBIT growth 1Y-25.36%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year76.34%

EBIT Next 3Y48.22%

EBIT Next 5Y32.37%

FCF growth 1Y-237.62%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-161.56%

OCF growth 3YN/A

OCF growth 5YN/A

BOEING CO/THE / BA FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

ChartMill assigns a fundamental rating of 1 / 10 to BA.

What is the valuation status of BOEING CO/THE (BA) stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.

Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 0 / 10.

How financially healthy is BOEING CO/THE?

The financial health rating of BOEING CO/THE (BA) is 1 / 10.

BOEING CO/THE (BA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

BOEING CO/THE / BA FAQ

Can you provide the ChartMill fundamental rating for BOEING CO/THE?

What is the valuation status of BOEING CO/THE (BA) stock?

Can you provide the profitability details for BOEING CO/THE?

How financially healthy is BOEING CO/THE?